Coverage
-
May 27, 2016
Chelsea Therapeutics International Inc. has agreed to pay $5.5 million in cash to settle an investor's putative securities class action stemming from alleged misstatements about its blood pressure drug Northera, the investor told a North Carolina federal court Friday.
1 other articles on this case.
View all »